A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
Stretching Your Dollar: What to Know About Changes to FAFSA
Applying for financial aid for college is a long process but there's a new streamlined application for federal student aid. Mark Kantrowitz, student loan expert, joined Cheddar News to explain the FAFSA form and what kind of changes are expected.
Stretching Your Dollar: Caring for Your Pets This Holiday Season
With all of the stress surrounding the holiday season with gift-buying and planning family gatherings, it could be a chaotic time for all members of your family, including pets. Cesar Milan and Michael Ehrman, co-founders of Halo Collar, joined Cheddar News to provide tips on how to keep your pets stress-free for the upcoming holiday season.
Load More